Several weeks ago I had the opportunity to discuss a series of cases of locally advanced NSCLC with a couple of expert colleagues: Dr. George Blumenschein, medical oncologist in the Division of Thoracic & Head/Neck Oncology at MD Anderson Cancer Center in Houston, TX; and Dr. Walter Curran, radiation oncologist who heads the Division of Radiation Oncology at the Winship Cancer Center at Emory University in Atlanta, GA. Dr. Curran is also the head of the Radiation Therapy Oncology Group, the US-based cooperative oncology group leading important questions about radiation oncology in various cancer types.

The first of the cases we covered is a patient of mine with stage IIIA N2 NSCLC, the most controversial setting in lung cancer management, where many options are all considered as reasonable alternatives throughout the oncology field.

Here's the audio and video versions of the podcast, along with the transcript and figures.

stage-iiia-n2-nsclc-case-drs-blumenschein-and-curran-audio-podcast

stage-iiia-n2-nsclc-case-drs-blumenschein-and-curran-transcript

stage-iiia-n2-nsclc-case-drs-blumenschein-and-curran-figs

This will be followed by a discussion of a Pancoast tumor and then one of someone with an unresectable locally advanced NSCLC.

This program is supported by an educational grant from OSI Pharmaceuticals. We thank them for their support.